Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Role of Prostaglandin-Endoperoxide Synthase-2 in Chemoresistance of Non-Small Cell Lung Cancer

8 Aug 2019

Abstract excerpt

The prostaglandin endoperoxide synthase-2 (PTGS2) plays essential roles in diverse pathological process. Although recent studies implied PTGS2 was closely related with chemoresistance, the precise roles and the underlying mechanisms of PTGS2 in the developing process of chemoresistance in non-small cell lung cancer (NSCLC) remained elusive. In the present study, we revealed a novel molecular mechanism of PTGS2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Transport and Resistance Mechanisms
Share to Inflammatory mediators and NSAID effects
Share to Peptidase Inhibition and Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31440159
DOI: 10.3389/fphar.2019.00836

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Role of Prostaglandin-Endoperoxide Synthase-2 in Chemoresistance of Non-Small Cell Lung CancerPMID 31440159Read ↗

EREG increases stemness associated genes expression and promotes Chemoresistance of non-small cell lung cancer via ERK signalingSemantic proximity Read ↗

MiR-200c-3p and miR-485-5p overexpression elevates cisplatin sensitivity and suppresses the malignant phenotypes of non-small cell lung cancer cells through targeting RRM2.Semantic proximity Read ↗

Long non-coding RNA ACTA2-AS1 inhibits the cisplatin resistance of non-small cell lung cancer cells through inhibiting autophagy by suppressing TSC2Semantic proximity Read ↗

Polymorphisms of COX/PEG2 pathway-related genes are associated with the risk of lung cancer: A case-control study in China.Semantic proximity Read ↗

ERK5 mediates pro-tumorigenic phenotype in non-small lung cancer cells induced by PGE2.Semantic proximity Read ↗

PGAP6 drives chemotherapy resistance in Ewing sarcomaSemantic proximity Read ↗

ERO1L promotes NSCLC development by modulating cell cycle‐related moleculesSemantic proximity Read ↗

miR-181b inhibits chemoresistance in cisplatin-resistant H446 small cell lung cancer cells by targeting Bcl-2Semantic proximity Read ↗

Pemetrexed induces ROS generation and cellular senescence by attenuating TS-mediated thymidylate metabolism to reverse gefitinib resistance in non-small cell lung cancerSemantic proximity Read ↗

Ubiquitin-conjugating enzyme E2C regulates apoptosis-dependent tumor progression of non-small cell lung cancer via ERK pathwaySemantic proximity Read ↗

eEF2K knockdown synergizes STS to inhibit the angiogenesis of lung adenocarcinoma via TG2/IL-6/VEGFR2 pathwaySemantic proximity Read ↗

Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.